Current and Emerging Treatment Regimens for HER2-Positive Breast Cancer.

ABSTRACT: Overexpression of human epidermal growth factor receptor 2 (HER2) is an important factor in cancer survival, proliferation, and metastasis. Agents that target HER2-positive tumors are used with traditional chemotherapies, with other targeted therapies, or as monotherapy to treat metastatic breast cancers.

SUBMITTER: Maher M 

PROVIDER: S-EPMC4005117 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature